Call Us Toll Free
at 1-800-561-1911

Research Studies

Understanding the Patient Experience for those with Parkinson disease who use SubcutaneousFoscarbidopa-Foslevodopa Infusion (VYALEV®)

This is a market research study being conducted by CRC Research, a Canadian market research company, togather findings and insights to aid in better understanding the patient experience and improve

Understanding the Patient Experience for those with Parkinson disease who use SubcutaneousFoscarbidopa-Foslevodopa Infusion (VYALEV®) Read More »